ACUTE ISCHEMIC STROKE DUE TO INTRACRANIAL LARGE-ARTERY ATHEROSCLEROSIS
Clinical trials for ACUTE ISCHEMIC STROKE DUE TO INTRACRANIAL LARGE-ARTERY ATHEROSCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new ACUTE ISCHEMIC STROKE DUE TO INTRACRANIAL LARGE-ARTERY ATHEROSCLEROSIS trials appear
Sign up with your email to follow new studies for ACUTE ISCHEMIC STROKE DUE TO INTRACRANIAL LARGE-ARTERY ATHEROSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Late-Stroke patients: drug trial uses advanced imaging to guide treatment
Disease control Recruiting nowThis Phase 3 trial tests whether the drug tirofiban can help people who have had a stroke but missed the usual treatment window (more than 24 hours after symptoms start). The study uses a special MRI scan to select patients whose stroke is caused by a specific type of artery bloc…
Matched conditions: ACUTE ISCHEMIC STROKE DUE TO INTRACRANIAL LARGE-ARTERY ATHEROSCLEROSIS
Phase: PHASE3 • Sponsor: Weifang Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New drug combo aims to boost stroke recovery
Disease control Recruiting nowThis study tests whether adding the drug tirofiban after a standard clot-removal procedure helps people recover better from a severe stroke caused by a blocked artery. About 716 adults will receive either tirofiban or a placebo right after the procedure. The main goal is to see i…
Matched conditions: ACUTE ISCHEMIC STROKE DUE TO INTRACRANIAL LARGE-ARTERY ATHEROSCLEROSIS
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC